the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Widening of JB-Simpang Renggam PLUS Highway to be completed in three years

JOHOR BAHRU: Phases One and Two of the project to widen the North-South Expressway (PLUS) from Johor Bahru to Simpang Renggam are expected to be completed in three years, said Johor Menteri Besar Datuk Onn Hafiz Ghazi.

He said the state government had also proposed to PLUS for the widening work to be implemented until Tangkak in the next phase.

He added that he also brought up and discussed other issues during his meeting with PLUS Malaysia Bhd managing director Datuk Nik Airina Nik Jaafar, especially regarding traffic flow and the maintenance and development of facility infrastructure for users.

“Among the proposals included activating the ‘smart lane’ or emergency lane on the expressway during peak hours and weekends and upgrading the facilities at the rest and service areas along the expressway.

“We also discussed the monitoring of the schedule to carry out upgrading or repair works on the expressway as well as controlling the movement time of lorries and containers. Hopefully, all the proposals can be carried out for the comfort of the people of Johor,” he wrote in a post on his Facebook page today.

Meanwhile, Onn Hafiz also thanked PLUS Malaysia for paying zakat (tithe) totalling RM650,000.

In October, Prime Minister Datuk Seri Anwar Ibrahim had, through Budget 2024, announced that the project to widen the PLUS Highway from four to six lanes will be extended from Sedenak to Simpang Renggam, involving RM931 million. – Bernama

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings